Sign in

Research summary ·

Glucocorticoid tapering strategies in polymyalgia rheumatica: a systematic literature review.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This review looked at ways to lower steroid doses in polymyalgia rheumatica. Steroids are the main drug for this disease. But the ideal way to slowly cut the dose is not known. The team searched large medical databases for studies that followed people forward. Some were trials where people were put in groups by chance. Others tracked groups of people as they were treated.

What they found

The time taken to lower the dose ranged from 16 to 80 weeks. Even so, results after one year looked fairly alike across studies. A similar share of people were in remission or off steroids. Flares were common in all of the studies. Flare rates did not seem to depend on how fast the dose fell. The total steroid dose varied a lot between studies. But it did not seem to depend on taper length. Few studies said how people felt, and each used its own way.

What it means for patients

Results looked broadly similar, even though taper length varied a lot. The authors say a faster taper may not lead to worse results. They call for studies on who responds well to treatment. They also want tests of tapers shaped to each person and a set goal. Shared ways to measure results are needed, the authors say. This includes reports from people about their own health.

Why it is not certain yet

The authors say the evidence is still limited. So it cannot show the ideal way to lower the dose. The studies were too different to pool their results. So the results were only described, not combined. Data on how people felt were sparse and varied. A review can only be as good as the studies in it.

Source

Glucocorticoid tapering strategies in polymyalgia rheumatica: a systematic literature review.

PubMed · PMID 41678240

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Polymyalgia rheumatica publications